新闻/Reuters/Curevac and GSK agree to resolve patent dispute litigation with Pfizer and BioNTechCurevac and GSK agree to resolve patent dispute litigation with Pfizer and BioNTechRefinitiv阅读少于1分钟CVACGSKPFEBNTXCurevac CVAC said on Thursday that the company and GSK GSK have entered an agreement to resolve patent dispute with Pfizer PFE and BioNTech BNTX over mRNA-based COVID-19 vaccines. Reuters德国股票欧洲美国股票英国股票财务报表© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html显示更多登录或创建永久免费帐户以阅读此新闻我们开始吧
